Healthcare entity

Shanghai Haohai Biological Technology Co., Ltd

Company

Every one of those 1 sits in a single category, market-trends. Intraocular Lenses is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 3.6 for the broader beat in this window.

Last mentioned: Mar 21, 2026

Entity pulse

Recent coverage · Shanghai Haohai Biological Technology Co., Ltd

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Shanghai Haohai Biological Technology Co., Ltd

Every one of those 1 sits in a single category, market-trends. Intraocular Lenses is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 3.6 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 5.9 for that window. We currently track 1 Healthcare story that mention Shanghai Haohai Biological Technology Co., Ltd, all published on March 21, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 20 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Shanghai Haohai Biological Technology Co., Ltd. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Shanghai Haohai Biological Technology Co., Ltd 1

Market Trends Neutral

Shanghai Haohai Biological Reports Full-Year Income Retreat Amid VBP Pressures

Shanghai Haohai Biological Technology Co., Ltd. has reported a retreat in its full-year net income, reflecting the intensifying impact of China's centralized procurement policies. The decline underscores the challenges facing domestic medtech leaders as they navigate margin compression in ophthalmology and heightened competition in the medical aesthetics market.

2 sources

Source: Rttnews · rttnews.com

Shanghai Haohai Biological Technology Co., Ltd is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.